Facet browsing currently unavailable
Page 1 of 3821 results
Sort by: relevance publication year
Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1 JOURNAL ARTICLE published 3 April 2017 in Expert Opinion on Therapeutic Patents Research funded by National Natural Science Foundation of China (81273354,81573347) | Science and Technology Development Project of Shandong Province (2014GSF118012,2014GSF118175) | Young Scholars Program of Shandong University (YSPSDU) | Key Project of NSFC for International Cooperation (30910103908,81420108027) | Major Project of Science and Technology of Shandong Province (2015ZDJS04001) |
New developments around histamine H3receptor antagonists/inverse agonists: a patent review (2010 – present) JOURNAL ARTICLE published January 2014 in Expert Opinion on Therapeutic Patents |
Protein kinase C inhibitors: a patent review (2008 – 2009) JOURNAL ARTICLE published October 2013 in Expert Opinion on Therapeutic Patents |
Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature JOURNAL ARTICLE published 1 December 2016 in Expert Opinion on Therapeutic Patents Research funded by National Institutes of Health (NIH AI117224) |
Inhibitors of human neutrophil elastase as a potential treatment for inflammatory diseases JOURNAL ARTICLE published July 1999 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published March 2003 in Expert Opinion on Therapeutic Patents |
Annotated Patent Selections JOURNAL ARTICLE published December 2006 in Expert Opinion on Therapeutic Patents |
HMG-CoA inhibitors for the treatment of cancer JOURNAL ARTICLE published September 1994 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published June 2007 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published April 2005 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published January 2006 in Expert Opinion on Therapeutic Patents |
Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation JOURNAL ARTICLE published August 2002 in Expert Opinion on Therapeutic Patents |
A patent review of adenosine A2Breceptor antagonists (2016-present) JOURNAL ARTICLE published 3 June 2022 in Expert Opinion on Therapeutic Patents |
Monoclonal antibody–drug conjugates JOURNAL ARTICLE published September 2005 in Expert Opinion on Therapeutic Patents |
Small molecules as activators in medicinal chemistry (2000–2016) JOURNAL ARTICLE published 3 October 2017 in Expert Opinion on Therapeutic Patents Research funded by Higher Education Commission, Pakistan (20-1910) |
Analysis of patents on anti-gout therapies issued in China JOURNAL ARTICLE published May 2014 in Expert Opinion on Therapeutic Patents |
Dopamine D3 receptor antagonists: a patent review (2007 – 2012) JOURNAL ARTICLE published March 2013 in Expert Opinion on Therapeutic Patents |
Exploring drug patent linkage and the first ANDA litigation in China JOURNAL ARTICLE published 2 November 2022 in Expert Opinion on Therapeutic Patents |
JOURNAL ISSUE published July 1994 in Expert Opinion on Therapeutic Patents |
New insights into the treatment of gastroesophageal reflux disease JOURNAL ARTICLE published October 2002 in Expert Opinion on Therapeutic Patents |